Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurocytotoxicity: pharmacological implications.

B K Siesjö1, H Memezawa, M L Smith

  • 1Laboratory for Experimental Brain Research, University of Lund, Sweden.

Fundamental & Clinical Pharmacology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acidosis promotes the permeability transition in energized mitochondria: implications for reperfusion injury.

Journal of neurotrauma·2001
Same author

Does long-term glucose infusion reduce brain damage after transient cerebral ischemia?

Brain research·2001
Same author

Protein aggregation after focal brain ischemia and reperfusion.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2001
Same author

Hyperglycemia enhances DNA fragmentation after transient cerebral ischemia.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2001
Same author

Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat.

Brain research·2001
Same author

Early release of cytochrome C and activation of caspase-3 in hyperglycemic rats subjected to transient forebrain ischemia.

Brain research·2001
Same journal

The Challenges of Scientific Publishing: An Editor-In-Chief's Perspective.

Fundamental & clinical pharmacology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms.

Fundamental & clinical pharmacology·2026
Same journal

TAAR1-Associated Trace Amines for Cutaneous Nociceptive Blockade in Rats.

Fundamental & clinical pharmacology·2026
Same journal

Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia-Reperfusion Injury.

Fundamental & clinical pharmacology·2026
Same journal

Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis- and Angiogenesis-Related Proteins.

Fundamental & clinical pharmacology·2026
Same journal

Nebivolol Protects the Thoracic and Abdominal Aorta and Their Perivascular Adipose Tissue From the Differential Detrimental Effects of Obesity.

Fundamental & clinical pharmacology·2026
See all related articles

Excitotoxicity contributes to brain damage, with NMDA receptor blockers effective in some conditions but not others. AMPA receptor blockers show promise for severe ischemia by blocking upstream events.

Area of Science:

  • Neuroscience
  • Pathophysiology
  • Pharmacology

Background:

  • Brain damage in ischemia and hypoglycemia involves excitotoxicity, triggered by glutamate release and calcium influx.
  • NMDA receptor antagonists reduce damage in focal ischemia and hypoglycemia, highlighting the role of calcium influx via NMDA receptors.

Purpose of the Study:

  • To investigate the differing therapeutic responses to NMDA and AMPA receptor blockers in various ischemic conditions.
  • To elucidate the distinct pathophysiological mechanisms underlying different types of ischemic brain injury.

Main Methods:

  • Utilized NMDA receptor antagonists (e.g., blocking NMDA type glutamate receptor) and AMPA receptor blockers (NBQX).
  • Compared the efficacy of these antagonists in models of focal ischemia (MCA occlusion), cardiac arrest, and forebrain ischemia.

Related Experiment Videos

Main Results:

  • NMDA antagonists were effective in focal ischemia and hypoglycemia but not in cardiac arrest or global forebrain ischemia.
  • AMPA receptor blocker NBQX demonstrated efficacy in cardiac arrest and global forebrain ischemia models.
  • Pathophysiology differs between MCA occlusion and cardiac arrest-induced ischemia, influencing therapeutic responses.

Conclusions:

  • Different ischemic conditions activate distinct calcium conductances, necessitating tailored therapeutic strategies.
  • AMPA receptor blockers may be beneficial in severe ischemia by inhibiting upstream excitation and sodium influx.
  • NMDA receptor blockers may be effective in focal ischemia by modulating calcium influx in energy-compromised cells.